0002035832-24-000001.txt : 20241002 0002035832-24-000001.hdr.sgml : 20241002 20241002153807 ACCESSION NUMBER: 0002035832-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241002 DATE AS OF CHANGE: 20241002 EFFECTIVENESS DATE: 20241002 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aktis Oncology, Inc. CENTRAL INDEX KEY: 0002035832 ORGANIZATION NAME: IRS NUMBER: 852584233 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-525672 FILM NUMBER: 241346924 BUSINESS ADDRESS: STREET 1: 17 DRYDOCK AVENUE STREET 2: SUITE #17-401 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 978-237-4380 MAIL ADDRESS: STREET 1: 17 DRYDOCK AVENUE STREET 2: SUITE #17-401 CITY: BOSTON STATE: MA ZIP: 02210 D 1 primary_doc.xml X0708 D LIVE 0002035832 Aktis Oncology, Inc. 17 DRYDOCK AVENUE SUITE #17-401 BOSTON MA MASSACHUSETTS 02210 978-237-4380 DELAWARE None None Corporation true 2020 Matthew Roden 17 DRYDOCK AVENUE Boston MA MASSACHUSETTS 02210 Executive Officer Director Todd Foley 17 DRYDOCK AVENUE Boston MA MASSACHUSETTS 02210 Director Oleg Nodelman 17 DRYDOCK AVENUE Boston MA MASSACHUSETTS 02210 Director Helen S. Kim 17 DRYDOCK AVENUE Boston MA MASSACHUSETTS 02210 Director Lloyd Segal 17 DRYDOCK AVENUE Boston MA MASSACHUSETTS 02210 Director Ken Herrmann 17 DRYDOCK AVENUE Boston MA MASSACHUSETTS 02210 Director Andrew Levin 17 DRYDOCK AVENUE Boston MA MASSACHUSETTS 02210 Director Shulamit Ron-Bigger 17 DRYDOCK AVENUE Boston MA MASSACHUSETTS 02210 Executive Officer Biotechnology Decline to Disclose 06b false 2024-09-20 false true false 0 175000000 175000000 0 false 39 0 0 0 false Aktis Oncology, Inc. Matthew Roden Matthew Roden CEO 2024-10-02